Blog: Increase "Efficiency and Effectiveness" to Expand Global ARV Supply
March 26, 2010
"Increased funding is necessary to expand access to [HIV] treatment, but it is not the only solution. Access can also be expanded by improving the efficiency and effectiveness of the global ARV supply chains, which has many moving parts and many bottlenecks. Unfortunately, these bottlenecks often persist because influential actors have no incentives to address them," according to the "Global Health Policy" blog post about a new paper (.pdf) on access to ARVs. "Though the paper does not attempt to solve the dozens of incentive misalignments identified, the authors offer one illustrative solution that they believe would help to realign many of the problematic incentives: an electronic marketplace for ARVs" (Wendt, 3/24).
EU-India Free-Trade Negotiations Could Limit Access to Affordable, Generic Drugs, Advocacy Group Says
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.